CDH5 and diabetic retinopathy: In accordance with the previous studies (Dejana et al, 2008; Hu et al, 2017), we also detected a discontinuity of VE‐cadherin and a reduction of N‐cadherin coverage in STZ‐induced diabetic retinopathy compared with the control group (Fig EV3C–F).